Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP7 | P09237 | 4/20 | 0.52 |
| ▸ | MMP10 | P09238 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 2/20 | 0.46 |
| ▸ | FLT1 | P17948 | 1/20 | 0.44 |
| ▸ | FLT4 | P35916 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.44 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7407679 | 0.93 | MMP7 (0.56) | MMP7MMP10MMP9RAB9AMMP13 | |
| SCHEMBL7410656 | 0.90 | MMP7 (0.58) | MMP7MMP10MMP9PSMB8RAB9A | |
| SCHEMBL7415732 | 0.89 | MMP7 (0.56) | MMP7MMP10MMP9RAB9AMMP13 | |
| SCHEMBL7418075 | 0.89 | MMP7 (0.55) | MMP7MMP10MMP9RAB9APSMB5 | |
| SCHEMBL7415213 | 0.89 | MMP7 (0.60) | MMP7MMP10MMP9RAB9AFLT1 | |
| SCHEMBL7416392 | 0.88 | MMP7 (0.62) | MMP7MMP10MMP9PSMB8MMP13 | |
| SCHEMBL7422957 | 0.86 | MMP7 (0.47) | MMP7MMP10MMP9RAB9AMMP13 | |
| SCHEMBL7417174 | 0.85 | MMP7 (0.58) | MMP7MMP10MMP9PSMB8RAB9A | |
| SCHEMBL7408585 | 0.85 | MMP7 (0.60) | MMP7MMP10MMP9RAB9AMMP13 | |
| SCHEMBL7418006 | 0.84 | MMP7 (0.47) | MMP7MMP10MMP9PSMB8RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6218389-B1 | FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES | THE PROCTER & GAMBLE CO. | 2001-04-17 | — | — | US | disclosed |
| EP-1009737-A2 | SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-21 | — | — | EP | disclosed |
| WO-1999006340-A2 | SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 1999-02-11 | — | — | WO | disclosed |